These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22906841)

  • 41. Multifunctional nanoparticles for brain tumor imaging and therapy.
    Cheng Y; Morshed RA; Auffinger B; Tobias AL; Lesniak MS
    Adv Drug Deliv Rev; 2014 Feb; 66():42-57. PubMed ID: 24060923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current major cancer targets for nanoparticle systems.
    Wesselinova D
    Curr Cancer Drug Targets; 2011 Feb; 11(2):164-83. PubMed ID: 21158716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic and diagnostic applications of nanoparticles.
    Youns M; Hoheisel JD; Efferth T
    Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanometric gold in cancer nanotechnology: current status and future prospect.
    Ahmad MZ; Akhter S; Rahman Z; Akhter S; Anwar M; Mallik N; Ahmad FJ
    J Pharm Pharmacol; 2013 May; 65(5):634-51. PubMed ID: 23600380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advancement in multifunctional nanoparticles for the effective treatment of cancer.
    Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Jalees Ahmed F; Anwar F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):367-81. PubMed ID: 22400808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic nanoparticles: a novel platform for cancer theranostics.
    Singh A; Sahoo SK
    Drug Discov Today; 2014 Apr; 19(4):474-81. PubMed ID: 24140592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.
    Ji T; Zhao Y; Ding Y; Nie G
    Adv Mater; 2013 Jul; 25(26):3508-25. PubMed ID: 23703805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymer-based cancer nanotheranostics: retrospectives of multi-functionalities and pharmacokinetics.
    Han N; Yang YY; Wang S; Zheng S; Fan W
    Curr Drug Metab; 2013 Jul; 14(6):661-74. PubMed ID: 23869810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms for targeted delivery of nanoparticles in cancer.
    Beech JR; Shin SJ; Smith JA; Kelly KA
    Curr Pharm Des; 2013; 19(37):6560-74. PubMed ID: 23621529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
    Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
    Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.
    Kievit FM; Zhang M
    Adv Mater; 2011 Sep; 23(36):H217-47. PubMed ID: 21842473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies.
    Ahmad K; Rabbani G; Baig MH; Lim JH; Khan ME; Lee EJ; Ashraf GM; Choi I
    Curr Drug Metab; 2018; 19(10):839-846. PubMed ID: 28831911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.
    Cheng Z; Al Zaki A; Hui JZ; Muzykantov VR; Tsourkas A
    Science; 2012 Nov; 338(6109):903-10. PubMed ID: 23161990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.